Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
Keiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
International Journal of Clinical Oncology (2020) Vol. 25, Iss. 8, pp. 1459-1474
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp, Margarita Cariolou, Ioanna Tzoulaki, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 450
Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?
Øystein Bruserud, Helene Hersvik Aarstad, Tor Henrik Anderson Tvedt
Cancers (2020) Vol. 12, Iss. 7, pp. 1966-1966
Open Access | Times Cited: 47
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses
Georges Mjaess, Roy Chebel, Aya Karam, et al.
Acta Oncologica (2021) Vol. 60, Iss. 6, pp. 704-713
Open Access | Times Cited: 39
Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides
Qingyuan Zheng, Rui Yang, Xinmiao Ni, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5807-5807
Open Access | Times Cited: 24
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
International Journal of Clinical Oncology (2021) Vol. 27, Iss. 1, pp. 59-71
Open Access | Times Cited: 30
C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis
Yu Fujiwara, Alexander B. Karol, Himanshu Joshi, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104352-104352
Open Access | Times Cited: 4
Correlation between hemoglobin and the risk of common malignant tumors: a 1999–2020 retrospective analysis and causal association analysis
Guosheng Li, Tao Huang, Jing-Xiao Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta‐analysis
Xinhao Niu, Zhe Zhu, Juan Bao
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Radical cystectomy mortality in older patients: a systematic review and meta‐analysis
Jake Tempo, Sulleyman Felemban, Kirby R. Qin, et al.
BJU International (2025)
Open Access
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
Victor M. Schuettfort, David D’Andrea, Fahad Quhal, et al.
BJU International (2021) Vol. 129, Iss. 2, pp. 182-193
Open Access | Times Cited: 23
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
Keiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, et al.
World Journal of Urology (2022) Vol. 41, Iss. 4, pp. 909-919
Open Access | Times Cited: 13
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy
Markus von Deimling, Victor M. Schuettfort, David D’Andrea, et al.
Clinical Genitourinary Cancer (2023) Vol. 21, Iss. 4, pp. 430-441
Closed Access | Times Cited: 6
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder
Victor M. Schuettfort, Kilian M. Gust, David D’Andrea, et al.
Minerva Urology and Nephrology (2022) Vol. 74, Iss. 3
Closed Access | Times Cited: 10
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy
Hang Xu, Tianhai Lin, Jianzhong Ai, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1733-1744
Open Access | Times Cited: 5
Prognostic Value of the Albumin-to-Globulin Ratio in Patients with Colorectal Cancer: A Meta-Analysis
Longfang Quan, Xiaohan Jiang, Xiaoqiang Jia, et al.
Nutrition and Cancer (2022) Vol. 74, Iss. 9, pp. 3329-3339
Closed Access | Times Cited: 9
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review
Ekaterina Laukhtina, Benjamin Pradère, Keiichiro Mori, et al.
Urologic Oncology Seminars and Original Investigations (2021) Vol. 39, Iss. 8, pp. 471-479
Open Access | Times Cited: 10
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
Keiichiro Mori, Victor M. Schuettfort, Satoshi Katayama, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 8, pp. 5307-5316
Open Access | Times Cited: 7
Prognostic value of preoperative platelet-related parameters and plasma fibrinogen in patients with non-muscle invasive bladder cancer after transurethral resection of bladder tumor
Yutong Song, Junqiang Tian, Li Yang, et al.
Future Oncology (2022) Vol. 18, Iss. 26, pp. 2933-2942
Open Access | Times Cited: 7
Prognostic value of pretreatment serum albumin−globulin ratio in urothelial carcinoma: A systematic review and meta-analysis
Zhongyou Xia, Xueqin Fu, Jinze Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Impact of sarcopenia on outcomes of bladder cancer undergoing radical cystectomy: A systematic review and meta-analysis
F. Xiao-Feng Qin, Jiacheng Wu
Scottish Medical Journal (2024) Vol. 69, Iss. 2, pp. 26-36
Closed Access | Times Cited: 1
Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
Shinji Tsukamoto, Andreas F. Mavrogenis, Rebeca Angulo Alvarado, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 1116-1131
Open Access | Times Cited: 3
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors—A Retrospective Data Analysis of 3075 Patients
Menachem Laufer, Maxim Perelman, Gad Segal, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 174-174
Open Access | Times Cited: 3
Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer
Shiqiang Su, Lizhe Liu, Chao Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
Keiichiro Mori, Victor M. Schuettfort, Satoshi Katayama, et al.
European Urology Focus (2021) Vol. 8, Iss. 4, pp. 972-979
Open Access | Times Cited: 5
Letter to the Editor for the Article “Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma”
Fumihiko Urabe, Shunsuke Tsuzuki, Takahiro Kimura
Annals of Surgical Oncology (2024) Vol. 31, Iss. 5, pp. 3563-3564
Closed Access
Page 1 - Next Page

Scroll to top